Loading clinical trials...
Loading clinical trials...
Open-label, multicentre, randomized clinical trial to compare the pharmacokinetics of ENVARSUS® tablets and ADVAGRAF® capsules administered once daily in adult de-novo kidney transplant patients.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Chiesi Farmaceutici S.p.A.
NCT07394660 · Organ or Tissue Transplant; Complications, Reiki
NCT01525329 · Actinic Keratosis, Organ or Tissue Transplant; Complications
Nephrology Department Hopital La Cavale Blanche
Brest
Clinique de Nephrologie CHU Grenoble
Grenoble
CHU Limoges
Limoges
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions